Tema ETFs’s Genmab GMAB Stock Holding History

Tema ETFs’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-132,043	Closed	-$4.05M	–	578
2025 Q3	$4.05M	Buy	132,043 +1,826	+1%	+$44.5K	0.34%	91
2025 Q2	$2.69M	Buy	130,217 +27,468	+27%	+$564K	0.71%	52
2025 Q1	$2.01M	Buy	102,749 +43,814	+74%	+$919K	0.6%	56
2024 Q4	$1.23M	Buy	+58,935	New	+$1.29M	0.51%	51

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Tema ETFs's GMAB Position: Q4 2025 in Review

Tema ETFs sold out of Genmab (GMAB) in Q4 2025, closing a stake of 132,043 shares — an estimated $4.05M sold.

Tema ETFs first reported a position in GMAB in Q4 2024 and held it in 4 quarters. The position peaked at $4.05M in Q3 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

Tema ETFs reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
Tema ETFs sold 132,043 Genmab shares in Q4 2025, an estimated $4.05M.
Tema ETFs first reported a position in Genmab in Q4 2024 and held it in 4 quarters.
Tema ETFs's Genmab position peaked at $4.05M in Q3 2025.
293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on Tema ETFs's 13F filing for Q4 2025, filed 16 Jan 2026.